Severe Hepatitis Outbreak Post COVID-19: How Do We Protect Our Children?

Zahra Abbas1, Omer A Shaikh2, Manisha Essarani3

  • 1Department of Medicine, Dow University of Health Sciences, Karachi, PAK.

Cureus
|October 13, 2022
PubMed

Insights

Severe acute hepatitis cases in children are rising alarmingly. Global strategies are needed to manage the increasing healthcare system workload and prevent further worsening.

Area of Science:

  • Hepatology
  • Pediatric Infectious Diseases
  • Public Health

Background:

  • Editorial addresses the significant global rise in pediatric severe acute hepatitis cases of unknown origin.
  • Highlights the escalating burden on healthcare systems due to this emerging health concern.

Discussion:

  • Emphasizes the urgent need for coordinated international strategies to address the unknown etiology of pediatric hepatitis.
  • Discusses the potential strain on healthcare resources and the necessity for proactive public health interventions.

Key Insights:

  • The increasing incidence of unexplained severe acute hepatitis in children is a critical global health issue.
  • Current healthcare systems face a substantial and growing workload due to this condition.

Outlook:

  • Recommends the development and implementation of global action plans for surveillance, diagnosis, and management.
  • Stresses the importance of collaborative research to identify the etiological agents and risk factors.
  • Calls for strengthening healthcare infrastructure to cope with the rising pediatric caseload.

Related Concept Videos

Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.1K
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.9K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.4K
Vaccinations01:51

Vaccinations

Overview
45.2K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
907
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K